Gentherm Inc THRM

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Con 31 acciones de THRM (USD 1.011,07) habrías recibido USD 117,80 en dividendos en los últimos 12 meses.

• Zacks Investment Research 14 sept

  THRM vs. RACE: Which Stock Should Value Investors Buy Now?

  In a comparison of two automotive stocks, Gentherm (THRM) emerges as the superior value opportunity compared to Ferrari (RACE). THRM holds a Zacks Rank #1 (Strong Buy) with a Value grade of A, supported by a forward P/E of 13.29 and PEG ratio of 0.89. RACE, rated #3 (Hold) with a Value grade of D, has a forward P/E of 36.85 and PEG ratio of 3.54, indicating significantly higher valuations.

  

• GlobeNewswire Inc. 10 sept

  Gentherm Shareholders Approve Combination with Modine’s Performance Technologies Business

  Gentherm shareholders voted to approve the proposed combination with Modine's Performance Technologies business, with approximately 99% voting in favor of share issuance and 94% supporting charter amendments. The transaction has received all required regulatory approvals and is expected to close on October 1, 2026. The combined entity aims to create a higher-growth, higher-margin thermal and precision flow management business.

  

• GlobeNewswire Inc. 22 jul

  Gentherm Acquires Innovative Medical Equipment, LLC, Strengthening Medical Product Portfolio and Customer Channels

  Gentherm announced the acquisition of Innovative Medical Equipment, LLC (IME), a Cleveland-based provider of the ThermaZone® thermal therapy device. The acquisition expands Gentherm's medical product portfolio and customer base in healthcare, supporting the company's strategy to leverage its thermal management expertise into new markets. The deal is expected to deliver revenue synergies through expanded customer relationships and channels.

  

• GlobeNewswire Inc. 20 jul

  Gentherm Medical Receives FDA Clearance for ThermAffyx™ Patient Safety System

  Gentherm announced FDA 510(k) clearance for its ThermAffyx Patient Safety System, a patented integrated device combining active patient warming, securement, and pressure reduction for robotic-assisted surgical procedures. Product trials begin in August with revenue expected in Q3 2026. The device addresses a critical gap where over 25% of robotic surgery patients experience hypothermia despite current warming interventions.

  

• GlobeNewswire Inc. 7 jul

  Gentherm Announces Date for 2026 Second Quarter News Release and Conference Call

  Gentherm announced it will report its second quarter 2026 financial results on July 23, 2026, followed by a conference call at 8 am ET. The company, a global leader in thermal management and pneumatic comfort technologies, will discuss results with investors via phone and webcast. A replay will be available for one year.